QA: Relmada Therapeutics INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001553643_2017_Relmada_Therapeutics_INC.pdf

Logs

Graph

Absolute values for 0001553643, Relmada Therapeutics INC

  xvar xval
0 AssetsCurrent 9,298,301
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 531,348
3 remainder_Assets 414,355
4 LiabilitiesCurrent 3,060,737
5 LiabilitiesNoncurrent 140,914
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,008,913
9 ResearchAndDevelopmentExpense 6,206,660
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 13,240,882
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 10,244,004
1 Liabilities 3,201,651
2 Expenses 16,215,573
3 Revenues 0
4 StockholdersEquity 7,042,353
5 NetIncome -2,974,691
6 ComprehensiveNetIncome -2,974,691
7 BaseVar 21,451,055
8 EconomicCapitalRatiobeforeLimitedLiability 1.84
9 EconomicCapitalRatio 2.92

Edgar->Model Mapping

Feature Distribution

Change over Time